Status:
TERMINATED
Quality of Care of Oncological Patients With HPN
Lead Sponsor:
Fresenius Kabi
Conditions:
Tumors and Home Parenteral Nutrition
Eligibility:
All Genders
18+ years
Brief Summary
Medical care for patients with home parenteral nutrition (HPN) is challenging. Among other aspects, the transition from the inpatient to the outpatient setting (discharge management), the organization...
Detailed Description
The HPN management will be evaluated by using a self-developed patient and a standardized quality of life questionnaire. Patients will be recruited at the participating hospital by their treating phy...
Eligibility Criteria
Inclusion
- Men and women with an initial prescription for HPN during the current hospital stay
- Planned PN must at least contain the macronutrients glucose and amino acids.
- Solid, malignant tumor
- Anticipated duration of the HPN is at least 28 days
- Age ≥18 years
- Full legal capacity or legal guardian available
- Fluent in German language
- Able to read and write in German language
- Signed patient informed consent form
- Indication for PN
Exclusion
- Contraindication for PN
- ECOG performance status \>3
- Pregnant and breast-feeding women
- Concurrent participation in another clinical study that requires deviations from the hospital's routine PN, nutrition and/or nursing procedures
Key Trial Info
Start Date :
October 15 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 14 2022
Estimated Enrollment :
143 Patients enrolled
Trial Details
Trial ID
NCT03425435
Start Date
October 15 2018
End Date
January 14 2022
Last Update
February 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medizinische Hochschule Hannover
Hanover, Germany, 30623